What is ResMed's accounts payable?

ResMed (RMD) reported accounts payable of $273.3M in Q1 2026.

How has ResMed's accounts payable changed year-over-year?

ResMed's accounts payable increased by 22.8% year-over-year, from $222.56M to $273.3M.

What is the long-term trend for ResMed's accounts payable?

Over 4 years (2021 to 2025), ResMed's accounts payable has grown at a 19.2% compound annual growth rate (CAGR), from $138.01M to $278.16M.

What does accounts payable mean?

Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.

ResMed RMD Accounts Payable

Accounts Payable at other companies

Eli LillyLLY

$5.03B+46.1%

InogenINGN

$32.7M-9.0%

Inspire Medical SystemsINSP

$41.85M+43.6%

Viemed Healthcare, Inc.VMD

$8.58M+7.9%

LivaNovaLIVN

$99.15M+13.1%

Pulmonx CorporationLUNG

$3.47M-18.8%

Other financials

Income statement

See full

Revenue$1.4B+10.8%

Gross profit$891.0M+16.3%

Operating income$499.8M+17.3%

Net income$398.7M+9.2%

EPS (diluted)$2.74+10.5%

Balance sheet

See full

Cash & equivalents$1.7B+78.0%

Total debt$1.1B+29.8%

Total equity$6.5B+17.1%

Total assets$8.8B+16.1%

Cash flow

See full

Operating cash flow$554.1M-4.2%

CapEx$33.7M+61.8%

Free cash flow$520.5M-6.7%

Valuation

See full

Market cap$28.27B-19.1%

Enterprise value$27.71B-19.8%

P/E18.6×-6.3×

P/S5.1×-1.7×

Profitability

See full

Gross margin61.6%+2.8pp

Operating margin34.2%+2.1pp

Net margin27.4%+1.3pp

FCF margin31.7%+0.4pp

Returns & leverage

See full

Return on equity25.2%-0.6pp

Debt / equity0.2×0.0×

Current ratio3×-0.4×

Where this comes from

Reported directly by ResMed in its filing.

Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.

The official record: ResMed’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about ResMed's accounts payable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is ResMed's accounts payable?: ResMed (RMD) reported accounts payable of $273.3M in Q1 2026.
How has ResMed's accounts payable changed year-over-year?: ResMed's accounts payable increased by 22.8% year-over-year, from $222.56M to $273.3M.
What is the long-term trend for ResMed's accounts payable?: Over 4 years (2021 to 2025), ResMed's accounts payable has grown at a 19.2% compound annual growth rate (CAGR), from $138.01M to $278.16M.
What does accounts payable mean?: Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.